Telcagepant is an investigational drug.
There have been 11 clinical trials for Telcagepant.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 15th 2007.
The most common disease conditions in clinical trials are Migraine Disorders, Heart Diseases, and Vascular Diseases. The leading clinical trial sponsors are Merck Sharp & Dohme Corp. and [disabled in preview].